The abstract of Phase Ib expansion study ofCX-5461 in patients with solid tumors and BRCA2 and/orPALB2 mutation has been accepted at 2024 ESMO Congress
Location: San Diego Convention Center in San Diego, California, USA.
Content: The company’s major focus is engaging with academic and industry researchers as well as with clinicians in person, make new connections, and explore potential collaboration opportunities, which may include cooperation in clinical trials, licensing agreements, introducing late-stage or marketed novel drugs to expand the company's current product line. Please find details via https://aacr2mapyourshow.com/8_0/exhibitor/exhibitor-details.cfm?exhid=3858885